N. Amos

523 total citations
15 papers, 403 citations indexed

About

N. Amos is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, N. Amos has authored 15 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in N. Amos's work include Systemic Lupus Erythematosus Research (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). N. Amos is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). N. Amos collaborates with scholars based in United Kingdom, United States and Malaysia. N. Amos's co-authors include Bryan Williams, Lee‐Suan Teh, P. Charles, David Isenberg, Elaine M. Hay, P. Emery, J. Camilleri, J D Jessop, Matthew M. Harper and Lisa A. Williams and has published in prestigious journals such as British Journal of Pharmacology, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

N. Amos

14 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Amos United Kingdom 11 214 184 146 54 53 15 403
Panayi Gs United Kingdom 10 194 0.9× 155 0.8× 113 0.8× 49 0.9× 48 0.9× 28 391
Isaac Abadi Venezuela 8 349 1.6× 247 1.3× 78 0.5× 43 0.8× 25 0.5× 9 435
Tiange Lu Australia 7 202 0.9× 165 0.9× 102 0.7× 23 0.4× 63 1.2× 11 389
Viviana Antonella Pacucci Italy 9 302 1.4× 208 1.1× 92 0.6× 31 0.6× 71 1.3× 17 466
L M Vilá Puerto Rico 5 439 2.1× 188 1.0× 80 0.5× 20 0.4× 23 0.4× 7 507
M Viana Queiróz Portugal 11 198 0.9× 89 0.5× 65 0.4× 42 0.8× 64 1.2× 23 348
Aarat Patel United States 8 158 0.7× 97 0.5× 65 0.4× 52 1.0× 32 0.6× 16 297
Ildikó Fanny Horváth Hungary 12 191 0.9× 177 1.0× 67 0.5× 35 0.6× 39 0.7× 18 465
Ravi Rao United Kingdom 5 184 0.9× 109 0.6× 43 0.3× 66 1.2× 22 0.4× 8 336
D F Huang Taiwan 9 98 0.5× 186 1.0× 116 0.8× 30 0.6× 39 0.7× 12 308

Countries citing papers authored by N. Amos

Since Specialization
Citations

This map shows the geographic impact of N. Amos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Amos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Amos more than expected).

Fields of papers citing papers by N. Amos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Amos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Amos. The network helps show where N. Amos may publish in the future.

Co-authorship network of co-authors of N. Amos

This figure shows the co-authorship network connecting the top 25 collaborators of N. Amos. A scholar is included among the top collaborators of N. Amos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Amos. N. Amos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Amos, N.. (2021). Utilizing Case Studies to Increase Engagement and Better Learning Outcomes in Secondary Science Education. 10(1).
2.
Reynolds, S. R. M., A. Olufemi Williams, Stephen T. Smale, et al.. (2012). Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase‐9. British Journal of Pharmacology. 167(3). 505–514. 19 indexed citations
3.
Carty, Sara, N. Amos, Sarah N. Lauder, et al.. (2010). Interferon-γ inhibits interleukin-1β-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis. Arthritis Research & Therapy. 12(2). R49–R49. 54 indexed citations
4.
Siebert, Stefan, et al.. (2007). Cytokine Production by Hepatic Anaplastic Large-Cell Lymphoma Presenting as a Rheumatic Syndrome. Seminars in Arthritis and Rheumatism. 37(1). 63–67. 14 indexed citations
5.
Man, Stephen, Eddie C. Y. Wang, Sheila Williams, et al.. (2001). Functional differences between influenza A-specific cytotoxic T lymphocyte clones expressing dominant and subdominant TCR. International Immunology. 13(11). 1383–1390. 30 indexed citations
6.
Camilleri, J., N. Amos, Bryan Williams, et al.. (2001). Serum soluble interleukin 2 receptor levels and radiological progression in early rheumatoid arthritis.. PubMed. 28(12). 2576–8. 4 indexed citations
7.
Hall, Frances, Daniel E. Weeks, J. Camilleri, et al.. (1996). Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. QJM. 89(11). 821–830. 64 indexed citations
8.
Teh, Lee‐Suan, P. Charles, George D. Nicholson, et al.. (1993). ANTIRIBOSOMAL P PROTEIN ANTIBODIES IN DIFFERENT POPULATIONS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Lara D. Veeken. 32(8). 663–665. 48 indexed citations
9.
Teh, Lee‐Suan, Elaine M. Hay, N. Amos, et al.. (1993). ANTI-P ANTIBODIES ARE ASSOCIATED WITH PSYCHIATRIC AND FOCAL CEREBRAL DISORDERS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Lara D. Veeken. 32(4). 287–290. 31 indexed citations
10.
11.
Teh, Lee‐Suan, David Isenberg, Caroline Gordon, et al.. (1992). Antibodies to protein P in systemic lupus erythematosus.. Annals of the Rheumatic Diseases. 51(4). 489–494. 64 indexed citations
12.
O’Sullivan, Margaret, et al.. (1990). Complement-mediated inhibition of immune precipitation in rheumatoid vasculitis. Rheumatology International. 10(4). 159–163. 4 indexed citations
13.
Amos, N., et al.. (1989). Autoantibody analysis in chronic graft-versus-host disease.. PubMed. 4(5). 529–31. 15 indexed citations
14.
O’Sullivan, Margaret, N. Amos, & Bryan Williams. (1988). Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.. Annals of the Rheumatic Diseases. 47(8). 675–680. 9 indexed citations
15.
Woo, P, P J Lachmann, R. A. Harrison, et al.. (1985). Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases.. PubMed. 61(1). 1–8. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Panayi Gs Breakdown of academic impact, for papers by Isaac Abadi Breakdown of academic impact, for papers by Tiange Lu Breakdown of academic impact, for papers by Viviana Antonella Pacucci Breakdown of academic impact, for papers by L M Vilá Breakdown of academic impact, for papers by M Viana Queiróz Breakdown of academic impact, for papers by Aarat Patel Breakdown of academic impact, for papers by Ildikó Fanny Horváth Breakdown of academic impact, for papers by Ravi Rao Breakdown of academic impact, for papers by D F Huang
Rankless by CCL
2026